1S62

Solution structure of the Escherichia coli TolA C-terminal domain

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1.4mM U-15N, 100mN NaCl, 50mM NaPO4, 90% H2O, 10% D2O	90% H2O/10% D2O	100mN NaCl, 50mM NaPO4	6.8	ambient	300
2	3D_13C-separated_NOESY	0.5mM U-15N,13C, 50mN NaCl, 50mM NaPO4, Complete protease inhibitor (Boehringer), 90% H2O, 10% D2O	90% H2O/10% D2O	50mN NaCl, 50mM NaPO4	6.8	ambient	300
3	3D_15N-separated_NOESY	0.7mM U-15N, 500mN NaCl, 50mM NaPO4, 90% H2O, 10% D2O	90% H2O/10% D2O	500mN NaCl, 50mM NaPO4	6.8	ambient	300

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	800

NMR Refinement
Method	Details	Software
2 step simulated annealing torsion angle dynamics		VNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	16
Representative Model	3 (closest to the average)

Additional NMR Experimental Information
Details	NOE mixing time of 0.08 s, triple-resonance probe including shielded z-gradients

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR		varian
2	processing	Felix	2000	Accelrys
3	data analysis	Felix	2000	Accelrys
4	structure solution	ARIA	1.0	Nilges
5	structure solution	TALOS		Cornilescu
6	refinement	TALOS		Cornilescu

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.